Previous 10 | Next 10 |
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, October 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. T...
Summary CONMED continues to attract sellers this week as equity markets continue digesting the latest macroeconomic data. Whilst unprofitable medtech has shone in recent years, it's failed to catch a bid in the July bounce, leaving names like CNMD behind. Quarterly operating p...
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20 th Annual Morgan Stanley Glob...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBr...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
CONMED ( NYSE: CNMD ) on Monday said it would acquire privately-held medical device start-up Biorez for a cash consideration of $85M at closing and up to an additional $165M in growth-based earnout payments over a four-year period. CNMD said it expects the deal to add ...
Through this acquisition, CONMED acquires next generation bioinductive collagen scaffold technology for application in sports medicine soft tissue healing CONMED to host conference call today at 4:30 p.m. ET CONMED Corporation (NYSE: CNMD) today a...
CONMED Corporation (CNMD) Q2 2022 Earnings Conference Call July 27, 2022 04:30 PM ET Company Participants Curt Hartman - Chairman, President & Chief Executive Officer Pat Beyer - President, CONMED International & Global Orthopaedics Todd Garner - Executiv...
The following slide deck was published by CONMED Corporation in conjunction with their 2022 Q2 earnings call. For further details see: CONMED Corporation 2022 Q2 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Conmed Corp. - Ordinary Shares Company Name:
CNMD Stock Symbol:
NASDAQ Market:
Conmed Corp. - Ordinary Shares Website:
2024-07-18 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participat...
2024-07-08 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...